Advertisement
UK markets close in 5 hours 7 minutes

  • FTSE 100

    8,056.31
    +32.44 (+0.40%)
     

  • FTSE 250

    19,707.33
    +107.94 (+0.55%)
     

  • AIM

    752.28
    +3.10 (+0.41%)
     

  • GBP/EUR

    1.1594
    +0.0005 (+0.04%)
     

  • GBP/USD

    1.2360
    +0.0010 (+0.08%)
     

  • Bitcoin GBP

    53,494.50
    +51.23 (+0.10%)
     

  • CMC Crypto 200

    1,422.16
    +7.40 (+0.52%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CRUDE OIL

    81.88
    -0.02 (-0.02%)
     

  • GOLD FUTURES

    2,312.50
    -33.90 (-1.44%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • DAX

    18,009.93
    +149.13 (+0.83%)
     

  • CAC 40

    8,072.63
    +32.27 (+0.40%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

Jim Halley, The Motley Fool
·5-min read
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Biogen (NASDAQ: BIIB) are developing remarkable therapies that, instead of merely treating disorders, have the potential to cure them or at least make an impact that no other drug has to date. The reason that's not a big cause for alarm is that the company's second-quarter revenue of $2.86 billion would be up 20% over the same period in 2021 if its COVID-19 therapy, REGEN-COV, was excluded from total revenue. The company's sales of the treatment ended late last year when government contracts for the therapy ended.

Continue reading